Free Trial
NYSE:NAVB

Navidea Biopharmaceuticals (NAVB) Stock Price, News & Analysis

Navidea Biopharmaceuticals logo
$0.0002 0.00 (0.00%)
As of 07/3/2025

About Navidea Biopharmaceuticals Stock (NYSE:NAVB)

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
N/A
52-Week Range
$0.00
$0.13
Volume
40 shs
Average Volume
8,821 shs
Market Capitalization
$20.02 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NAVB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

NAVB Stock News Headlines

Elon’s Revenge
Elon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is this: Before he left Washington, Elon Musk left a "parting gift" to folks, which could help you double your money multiple times this year. Everything you need to know is right here.
SK Biopharmaceuticals Co. Ltd.
See More Headlines

NAVB Stock Analysis - Frequently Asked Questions

Navidea Biopharmaceuticals' stock was trading at $0.0001 at the start of the year. Since then, NAVB shares have increased by 100.0% and is now trading at $0.0002.

Navidea Biopharmaceuticals, Inc. (NYSE:NAVB) announced its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.03. The company had revenue of $0.10 million for the quarter, compared to the consensus estimate of $0.60 million.

Shares of NAVB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Navidea Biopharmaceuticals investors own include Ampio Pharmaceuticals (AMPE), OPKO Health (OPK), CorMedix (CRMD), Sorrento Therapeutics (SRNE), Trevena (TRVN), Advanced Micro Devices (AMD) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
11/10/2021
Today
7/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:NAVB
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.13 thousand
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
56,367,000
Market Cap
$20.02 thousand
Optionable
Optionable
Beta
1.75
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NYSE:NAVB) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners